M. Foscoli

Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))

G. Hindricks, B. Lewis, M. Sabatine, 2019 .

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

G. Hindricks, B. Lewis, M. Sabatine, 2019, Atherosclerosis.

Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

G. Hindricks, B. Lewis, M. Sabatine, 2019, Atherosclerosis.

Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

G. Hindricks, B. Lewis, M. Sabatine, 2019, Atherosclerosis.

2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.

G. T. Gunnarsson, H. Heidbuchel, B. Lewis, 2020, European heart journal.

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

G. Hindricks, B. Lewis, M. Sabatine, 2019, Atherosclerosis.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

M. Sabatine, E. Hagström, D. Grobbee, 2019, European heart journal.